Hereditary nonpolyposis colorectal cancer surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hereditary nonpolyposis colorectal cancer}}
{{Hereditary nonpolyposis colorectal cancer}}
{{CMG}}{{AE}}{{MV}}  
{{CMG}}{{AE}}{{MV}}{{Akram}}


==Overview==
==Overview==

Revision as of 21:42, 6 February 2019

Hereditary Nonpolyposis Colorectal Cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hereditary Nonpolyposis Colorectal Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hereditary nonpolyposis colorectal cancer surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hereditary nonpolyposis colorectal cancer surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hereditary nonpolyposis colorectal cancer surgery

CDC on Hereditary nonpolyposis colorectal cancer surgery

Hereditary nonpolyposis colorectal cancer surgery in the news

Blogs on Hereditary nonpolyposis colorectal cancer surgery

Directions to Hospitals Treating Hereditary nonpolyposis colorectal cancer

Risk calculators and risk factors for Hereditary nonpolyposis colorectal cancer surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]Ali Akram, M.B.B.S.[3]

Overview

Surgery is the mainstay of treatment for hereditary nonpolyposis colorectal cancer. Surgical resection is recommended among patients with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous colorectal cancer. Subtotal colectomy with ileorectal anastomosis and postsurgical endoscopic rectal surveillance are advised when colorectal cancer develops in the setting of hereditary nonpolyposis colorectal cancer.

Surgery

  • Surgical resection is recommended among patients with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous colorectal cancer.
  • Common surgical techniques for the resection of hereditary nonpolyposis colorectal cancer, may include:
  • Surgical procedures for hereditary nonpolyposis colorectal cancer are characterized by increasing frequency of complications.
  • Complex surgical procedures are related with higher number of complications, but lower recurrence rates.
  • Patients with adenomas that are multiple and/or recurrent and/or of a significant degree of dysplasia and/or villous, prophylactic colectomy should be considered.
  • The high proportion of synchronous tumors (more than 15% of patients at the time of diagnosis) or metachronous tumors (about 45% during 10 years following surgery of the primary tumor) suggests that for preventive surgery as for surgery in patients from hereditary nonpolyposis colorectal cancer families with histopathologically diagnosed[1]

Common surgical complications of hereditary nonpolyposis colorectal cancer, may include:

  • Urinary tract abnormalities
  • Sexual dysfunction

Prophylactic Surgery

  • The feasibility of prophylactic surgery of the colon, uterus, and ovaries depends on a individual basis for hereditary nonpolyposis colorectal cancer patients.[2]
  • In some cases screen-detected family members and symptomatic individuals (young adults) are eligible for prophylactic colorectal surgery.
  • Prophylactic surgery should not be recommended to patients without any pathological changes of the colon even if such persons are carriers of a mutation.[3]

References

  1. 1.0 1.1 1.2 Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer ). Hered Cancer Clin Pract. 2008;6(2):99-102.
  2. Gryfe R (2009). "Inherited colorectal cancer syndromes". Clin Colon Rectal Surg. 22 (4): 198–208. doi:10.1055/s-0029-1242459. PMC 2796102. PMID 21037810.
  3. Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH (2006). "Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome". N. Engl. J. Med. 354 (3): 261–9. doi:10.1056/NEJMoa052627. PMID 16421367.


Template:WikiDoc Sources